<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04338555</url>
  </required_header>
  <id_info>
    <org_study_id>AES20200407</org_study_id>
    <nct_id>NCT04338555</nct_id>
  </id_info>
  <brief_title>Effects of TEAS on POCD</brief_title>
  <official_title>Effects of Transcutanclus Electrical Acupoint Stimulation on Postoperative Cognitive Dysfunction in Elderly Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RenJi Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>RenJi Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients undergoing elective orthopedics, urology, and general surgery will be included and&#xD;
      randomly allocated to TEAS group or control group . After routine anesthesia induction and&#xD;
      tracheal intubation, patients in TEAS group will receive electrical stimulation of acupoints&#xD;
      at Neiguan and Shenmen points. For patients in the control group, the electrodes will be only&#xD;
      attached to the corresponding sites, with no TEAS electrical stimulation given during the&#xD;
      operation. The primary outcome is the incidence of POCD at Day 7 after surgery. The secondary&#xD;
      outcomes include the incidence of POD during post-operative days 1-7, the incidence of POCD&#xD;
      at Day 30 after surgery, and the serum levels of cytokines, including IL-1β、IL-6、TNF-α、MMP9&#xD;
      on Day 1 after surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will enroll 110 patients who are older than 60 years old and will have elective&#xD;
      orthopedics, urology, or general surgeries under general anesthesia. Patients will be&#xD;
      randomly assigned to TEAS group and control group. After routine anesthesia induction and&#xD;
      tracheal intubation, patients in TEAS group will receive electrical stimulation of acupoints&#xD;
      at Neiguan and Shenmen points for 30min every hour. In other words, the patients will receive&#xD;
      TEAS stimulation for 30min, then no stimulation for 30min, then stimulation for another&#xD;
      30min, etc, until the end of the surgery. For patients in the control group, the electrodes&#xD;
      will be only attached to the corresponding sites, with no TEAS electrical stimulation given&#xD;
      during the operation. The primary outcome is the incidence of POCD at Day 7 after surgery.&#xD;
      The secondary outcomes include the incidence of POD during post-operative days 1-7, the&#xD;
      incidence of POCD at Day 30 after surgery, and the serum levels of cytokines, including&#xD;
      IL-1β、IL-6、TNF-α、MMP9 on Day 1 after surgery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 14, 2021</start_date>
  <completion_date type="Anticipated">April 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the incidence of POCD</measure>
    <time_frame>at Day 7 post-surgery</time_frame>
    <description>cognitive function of the patients will be analyzed with MMSE, Digital breadth, Number symbol, Visual regeneration, Color word conversion, Color Trail Marking Test (PartB) and CAM, and reflected by Z score with the following formula: Z=（Xafter-Xbefore）/SDbefore</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>the incidence of POCD</measure>
    <time_frame>at Day 30 post-surgery</time_frame>
    <description>cognitive function of the patients will be analyzed with MMSE, Digital breadth, Number symbol, Visual regeneration, Color word conversion, Color Trail Marking Test (PartB) and CAM, and reflected by Z score with the following formula: Z=（Xafter-Xbefore）/SDbefore</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the incidence of delirium</measure>
    <time_frame>from Day 1 to Day 7 post-surgery</time_frame>
    <description>whether the patients develop delirium will be analyzed with CAM</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>serum IL-1β level</measure>
    <time_frame>at Day 1 post-surgery</time_frame>
    <description>an inflammatory mediator that reflects systemic inflammation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>serum IL-6 level</measure>
    <time_frame>at Day 1 post-surgery</time_frame>
    <description>an inflammatory mediator that reflects systemic inflammation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>serum TNF-α level</measure>
    <time_frame>at Day 1 post-surgery</time_frame>
    <description>an inflammatory mediator that reflects systemic inflammation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>serum MMP9 level</measure>
    <time_frame>at Day 1 post-surgery</time_frame>
    <description>an inflammatory mediator that reflects systemic inflammation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Post-operative Cognitive Dysfunction</condition>
  <arm_group>
    <arm_group_label>TEAS group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in the TEAS group will receive electrical stimulation of acupoints at Neiguan and Shenmen points for 30min every hour. The stimulation will repeat until the end of surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>In patients from the control group, the electrodes will only be attached to the corresponding sites, with no TEAS electrical stimulation given during the operation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Transcutaneous electrical acupoint stimulation</intervention_name>
    <description>TEAS group will receive electrical stimulation of acupoints at Neiguan and Shenmen points for 30 min every hour during the surgery.</description>
    <arm_group_label>TEAS group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. ≧ 60 years old;&#xD;
&#xD;
          2. communicate normally；&#xD;
&#xD;
          3. ASA Physical Status 1-2;&#xD;
&#xD;
          4. Patients will have elective orthopedics, urology or general surgeries under general&#xD;
             anesthesia;&#xD;
&#xD;
          5. With an estimated surgery time of more than 2h;&#xD;
&#xD;
          6. Agree to participate the trial.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients with brain diseases or history of brain diseases;&#xD;
&#xD;
          2. Preoperative diagnosis of cognitive impairment by subtle mental state (MMSE) less than&#xD;
             24 points;&#xD;
&#xD;
          3. Patients with history of neurological and psychological disorders including AD,&#xD;
             stroke, and psychosis;&#xD;
&#xD;
          4. Severe hearing or visual impairment, illiteracy;&#xD;
&#xD;
          5. preoperative systolic blood pressure &gt;190mmHg, or diastolic blood pressure &gt;100mmHg;&#xD;
&#xD;
          6. Disagree to participate in this research;&#xD;
&#xD;
          7. Have used other medical electronic devices.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jie Tian</last_name>
    <role>Principal Investigator</role>
    <affiliation>RenJi Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jie Tian</last_name>
    <phone>86-21-68383702</phone>
    <email>vaseline2001@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Renji Hospital</name>
      <address>
        <city>Shanghai</city>
        <zip>200127</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jie Tian</last_name>
      <phone>86-21-68383702</phone>
      <email>vaseline2001@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>April 6, 2020</study_first_submitted>
  <study_first_submitted_qc>April 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 8, 2020</study_first_posted>
  <last_update_submitted>October 18, 2021</last_update_submitted>
  <last_update_submitted_qc>October 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>RenJi Hospital</investigator_affiliation>
    <investigator_full_name>Jie Tian</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Postoperative Cognitive Complications</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

